UI research could double survival rates for pancreatic cancer patients

Medical researchers at the University of Iowa report promising progress in fighting one of the worst cancer killers. The phase-two clinical trial found that adding high-dose, intravenous vitamin C to chemotherapy doubles the overall survival rate of patients with late-stage pancreatic cancer from eight months to 16. The study’s lead author says the results were […]

View Full Story

Share:

More